SD-208   Click here for help

GtoPdb Ligand ID: 8246

Synonyms: SCI-208 [2] | SD 208
Immunopharmacology Ligand
Compound class: Synthetic organic
Comment: SD-208 is a selective, ATP-competitive inhibitor of TGFβR1 (ALK5) [2]. SD-208 is compound 14 in patent WO2005032481 [1].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 6
Hydrogen bond donors 1
Rotatable bonds 3
Topological polar surface area 76.48
Molecular weight 352.06
XLogP 2.38
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES Clc1ccc(c(c1)c1nc(Nc2ccncc2)c2c(n1)nccn2)F
Isomeric SMILES Clc1ccc(c(c1)c1nc(Nc2ccncc2)c2c(n1)nccn2)F
InChI InChI=1S/C17H10ClFN6/c18-10-1-2-13(19)12(9-10)15-24-16-14(21-7-8-22-16)17(25-15)23-11-3-5-20-6-4-11/h1-9H,(H,20,22,23,24,25)
InChI Key BERLXWPRSBJFHO-UHFFFAOYSA-N
References
1. Chakravarty S, Conte A, Dugar S, Mcenroe G, Murphy A, Perumattam JJ. (2005)
Quinazoline derivatives as medicaments.
Patent number: WO2005032481. Assignee: Chakravarty S, Conte A, Dugar S, Mcenroe G, Murphy A, Perumattam JJ, Scios Inc.. Priority date: 30/09/2003. Publication date: 14/04/2005.
2. Raboisson P, Lenz O, Lin TI, Surleraux D, Chakravarty S, Scholliers A, Vermeiren K, Delouvroy F, Verbinnen T, Simmen K. (2007)
Evaluation of the anti-hepatitis C virus effect of novel potent, selective, and orally bioavailable JNK and VEGFR kinase inhibitors.
Bioorg Med Chem Lett, 17 (7): 1843-9. [PMID:17289388]